About LEO Pharma
LEO Pharma is a global leader in medical dermatology, delivering innovative treatments for skin diseases, building on a century of experience with breakthrough medicines in healthcare.
Patients served annually
+100M
Across 70+ countries
Dedicated employees
4,000
Advancing medical dermatology
Manufacturing sites
6
In Denmark, Ireland, France & Italy
With more than 60 years of specialist clinical development and commercial success in medical dermatology, we have developed deep expertise in one of healthcare’s most complex areas, encompassing over 1,000 conditions, high unmet needs, and diverse treatment approaches. Today, one in three people globally live with a skin condition, and with our presence in over 70 countries, we serve more than 90 million patients each year in the rapidly growing medical dermatology market.
This broad market presence gives us unique insight into diverse disease presentations and treatment needs, enabling us to turn innovation into meaningful patient impact. Supported by six state of the art manufacturing sites, we ensure reliable, high quality supply worldwide and offer a differentiated portfolio in medical dermatology – combining category‑leading, established brands with first‑in‑class innovations aimed at transforming the standard of care.
In addition to our leadership in medical dermatology, LEO Pharma is active in critical care, with a focused presence in the fields of thrombosis and immunooncology. We develop and deliver treatments for blood clots and rare cancers, addressing serious and lifethreatening conditions with significant unmet medical need.
Established in Denmark in 1908, LEO Pharma now employs over 4,000 people across 30 countries, all unified by our purpose: Together, we reach far beyond the skin.
Explore more
